Philip Morris International Inc. | Lobbying Expenditures Disclosure at Philip Morris International Inc.

Status
Withdrawn
AGM date
Previous AGM date
Resolution details
Company ticker
PM
Lead filer
Resolution ask
Report on or disclose
ESG theme
  • Governance
ESG sub-theme
  • Lobbying / political engagement
Type of vote
Shareholder proposal
Filer type
Shareholder
Company sector
Consumer Staples
Company HQ country
United States
Resolved clause
RESOLVED, the shareholders of Philip Morris International request the preparation of a report, updated annually, disclosing:
List of PMI payments for (a) direct or indirect lobbying or (b) grassroots lobbying communications, including the amount of the payment and recipient at the local, state (in the United States) and country levels.Company policy and procedures governing grassroots lobbying communications. The report shall be presented to the Nominating and Corporate Governance Committee and posted on PMI’s website.
Whereas clause
WHEREAS, we believe in full disclosure of Philip Morris International’s (“PMI”) direct and indirect lobbying activities and expenditures to assess whether the company’s lobbying is consistent with its expressed goals and in shareholders’ best interests.
Supporting statement
SUPPORTING STATEMENT: The tobacco industry’s longstanding role working to block laws and regulations that would protect citizens’ health is well documented around the world.[1] We believe PMI faces considerable reputational risk if it is not fully transparent about the lobbying it does and positions it promotes, especially related to tobacco. Companies like Altria have recently expanded their public reporting on lobbying they do directly and through third parties like trade associations.
Philip Morris International does not disclose its payments to trade associations and social welfare organizations, or amounts for lobbying at the country level and (in the case of the United States, state levels). including grassroots lobbying. Grassroots lobbying does not get reported in the United States under the federal Lobbying Disclosure Act, and disclosure is uneven or absent in states.
PMI recently expanded its lobbying activities in the US at the state level, since being authorized by the FDA to market its heated tobacco product IQOS in the US.
Controversy followed PMI’s establishment in 2017 and full funding of the 501c3 Foundation for a Smoke-Free World. Research by the University of Bath’s Tobacco Control Research Group found that much of the Foundation’s work “produced research and opinion which supports tobacco industry interests by side-lining evidence-based tobacco control measures and endorsing interventions which ensure the sale of industry products; advocating for tobacco industry involvement in science and policymaking; and misrepresenting evidence on tobacco and nicotine products.” PMI made its final grant payment of US$122.5 million to the Foundation in September 2023. [2]
The Secretariat for WHO’s Framework Convention on Tobacco Control, in preparation for the November 2023 Conference of Parties to the Convention “noted with concern that some Parties have been approached by the tobacco and other industry representatives, to offer travel and technical support, including advisors, for their official delegations” and to “remain vigilant in respect of any offer of support received from the tobacco industry.” [3] The Guardian reported that PMI “is waging a big lobbying campaign to prevent countries from cracking down on vapes and similar products”[4] for the Session.
We support greater transparency of PMI’s lobbying expenditures and activities in order to mitigate potential reputation and misalignment risks.
[1] https://www.uicc.org/news/tobacco-industry-interference-policy-decisions-undermines-effective-control, https://ncdalliance.org/sites/default/files/resource_files/NCDs_and_tobacco_Industry.pdf, https://www.phrp.com.au/issues/online-early/how-tobacco-companies-use-the-revolving-door-between-government-and-industry-to-influence-policymaking-an-australian-case-study/
[2] https://tobaccocontrol.bmj.com/content/early/2023/05/02/tc-2022-057667
[3] https://fctc.who.int/newsroom/news/item/14-08-2023-call-for-parties-to-remain-vigilant-in-preparation-for-the-cop10-and-the-mop3
[4] https://www.theguardian.com/business/2023/oct/12/philip-morris-lobbying-to-stop-who-attack-on-vapes-and-similar-products

DISCLAIMER: By including a shareholder resolution or management proposal in this database, neither the PRI nor the sponsor of the resolution or proposal is seeking authority to act as proxy for any shareholder; shareholders should vote their proxies in accordance with their own policies and requirements.

Any voting recommendations set forth in the descriptions of the resolutions and management proposals included in this database are made by the sponsors of those resolutions and proposals, and do not represent the views of the PRI.

Information on the shareholder resolutions, management proposals and votes in this database have been obtained from sources that are believed to be reliable, but the PRI does not represent that it is accurate, complete, or up-to-date, including information relating to resolutions and management proposals, other signatories’ vote pre-declarations (including voting rationales), or the current status of a resolution or proposal. You should consult companies’ proxy statements for complete information on all matters to be voted on at a meeting.